Stocktoria
Clene Inc. CLNN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-08-27
Clene Inc. statistics & valuation
Market cap$77.4M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -11541.5% | -9676.3% | -6198.8% | -10234.5% | -6912.6% |
| Net margin | -13086.5% | -11520.5% | -7569.4% | -6325.2% | -1347.2% |
| FCF margin | -9292.5% | -6240.1% | -4663.8% | -9342.5% | -4973.2% |
| Return on assets | -144.4% | -144.1% | -94.6% | -67.2% | -15.4% |
| Return on equity | 148.8% | 444.8% | -369.7% | -924.3% | -77.3% |
| Debt / equity | -1.01× | — | — | — | — |
| Current ratio | 0.83 | 1.57 | 1.53 | 2.11 | 9.06 |
| Revenue growth | -41.5% | -47.7% | 38.3% | -34.6% | 251.0% |
Source: SEC EDGAR filings · CIK 0001822791 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.